Ethics and stem cell therapeutics for cardiovascular disease

被引:4
|
作者
Sugarman, Jeremy
机构
[1] Johns Hopkins Univ, Berman Inst Bioeth, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ, Dept Hlth Policy & Management, Baltimore, MD 21218 USA
关键词
D O I
10.1016/j.pcad.2007.02.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
As research on stem cell therapeutics for the treatment of cardiovascular diseases in adults is being planned and conducted it is essential to address the ethical issues associated with it. The considerable attention that is currently focused on the ethical issues associated with stem cell research as well as the acute clinical situations sometimes encountered when treating cardiovascular disease, underscore the need for explicit attention to the ethical aspects of this research. In this article, I survey some of the key ethical considerations regarding research involving stem cell therapeutics for cardiovascular diseases including: (1) the standard ethical considerations for translational and clinical research and mechanisms of ethical oversight of them; (2) additional oversight related to stem cell research; (3) considerations for obtaining informed consent for this research and in selecting individual human subjects to participate in it; (4) concerns related to justice that may manifest themselves with respect to which research endeavors move forward and (5) conflicts of interest in research and their potential relationship to research integrity. © 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 50 条
  • [1] Stem-Cell Derived Exosomal microRNAs as Biomarkers and Therapeutics for Pediatric Cardiovascular Disease
    Aaron H. Wasserman
    Bana Abolibdeh
    Reema Hamdan
    Charles C. Hong
    Current Treatment Options in Cardiovascular Medicine, 2025, 27 (1)
  • [2] STEM CELL THERAPY FOR CARDIOVASCULAR DISEASE
    Jyothi, Nenavath
    Swetha, M. Sri
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2020, : 659 - 662
  • [3] Stem Cell Therapies in Cardiovascular Disease
    Terashvili, Maia
    Bosnjak, Zeljko J.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2019, 33 (01) : 209 - 222
  • [4] STEM CELL PROTEOMICS AND CARDIOVASCULAR DISEASE
    Xu Qingbo
    IFPT'6: PROGRESS ON POST-GENOME TECHNOLOGIES, PROCEEDINGS, 2009, : 7 - 7
  • [5] Stem cell therapy for cardiovascular disease
    Perin, Emerson C.
    TEXAS HEART INSTITUTE JOURNAL, 2006, 33 (02) : 204 - 208
  • [6] Emerging Strategies in Mesenchymal Stem Cell-Based Cardiovascular Therapeutics
    Kumar, Rishabh
    Mishra, Nitin
    Tran, Talan
    Kumar, Munish
    Vijayaraghavalu, Sivakumar
    Gurusamy, Narasimman
    CELLS, 2024, 13 (10)
  • [7] RNA Therapeutics in Cardiovascular Disease
    Lucas, Tina
    Bonauer, Angelika
    Dimmeler, Stefanie
    CIRCULATION RESEARCH, 2018, 123 (02) : 205 - 220
  • [8] RNA therapeutics for cardiovascular disease
    Boada, Christian
    Sukhovershin, Roman
    Pettigrew, Roderic
    Cooke, John P.
    CURRENT OPINION IN CARDIOLOGY, 2021, 36 (03) : 256 - 263
  • [9] Stem cell therapeutics: potential in the treatment of inflammatory bowel disease
    Swenson, E. S.
    Theise, N. D.
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2010, 3 : 1 - 10
  • [10] The use of stem cell therapy for cardiovascular disease
    Perin, EC
    TEXAS HEART INSTITUTE JOURNAL, 2005, 32 (03) : 390 - 392